FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics

FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics

Source: 
Medical Marketing and Media
snippet: 

News of the FTC’s pending challenge to the Amgen deal sunk Horizon’s stock during early morning trading Tuesday, with the company’s shares down more than 17%.